Host defence (cationic) peptides: what is their future clinical potential?

Area of Science:

• Biochemistry
• Immunology
• Microbiology

Background:

• Cationic antimicrobial peptides (CAPs) are crucial components of innate and induced host defenses against microbial invaders.
• These peptides are small (12-35 amino acids), positively charged, and adopt diverse secondary structures.
• They exhibit potent antimicrobial activity and possess favorable characteristics for therapeutic applications.

Purpose of the Study:

• To highlight the significance of cationic antimicrobial peptides in host defense.
• To underscore their potential as a novel class of antibiotics.
• To discuss their properties and therapeutic promise.

Main Methods:

• Review and synthesis of existing literature on cationic antimicrobial peptides.
• Analysis of their structural and functional characteristics.
• Evaluation of their in vitro and in vivo properties, including antimicrobial spectrum, resistance development, and endotoxin neutralization.

Main Results:

• Cationic antimicrobial peptides rapidly kill a broad spectrum of microorganisms, including drug-resistant bacteria and fungi.
• They demonstrate low in vitro resistance development and protect against topical and systemic infections.
• Synergy with conventional antibiotics and endotoxin neutralization capabilities were observed.

Conclusions:

• Cationic antimicrobial peptides represent a promising novel antibiotic class due to their potent activity and favorable properties.
• Their inherent diversity allows for the design of improved variants with enhanced therapeutic potential.
• Clinical trials are underway, particularly for topical treatment of polymicrobial infections, indicating significant therapeutic promise.